Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Unit price / market price
-
$1.06
-
Total 13F principal
-
$192,477,000
-
Principal change
-
+$10,278,389
-
Total reported value
-
$204,310,000
-
Number of holders
-
20
-
Value change
-
+$11,569,465
-
Number of buys
-
9
-
Number of sells
-
10
Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q2 2014
As of 30 Jun 2014 AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 had 20 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $192,477,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included DEERFIELD MANAGEMENT CO, STEELHEAD PARTNERS LLC, WOLVERINE ASSET MANAGEMENT LLC, Citadel Advisors LLC, SILVERBACK ASSET MANAGEMENT LLC, Castle Creek Arbitrage, LLC, Visium Asset Management, LP, Calamos Advisors LLC, Mohican Financial Management, LLC, and PALISADE CAPITAL MANAGEMENT LLC/NJ.
This table shows 20 bond principal holders of the security as of 30 Jun 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.